The macropinocytosis inhibitor EIPA can significantly reduce the uptake of a large amount of albumin and inhibit tumor xenograft growth of pancreatic carcinoma MIA PaCa-2 cells that display intensive macropinocytosis. This evidence concerns the gene ALB and exocrine pancreatic carcinoma.